
|Articles|July 14, 2015
New Release Clinical Conductor CTMS
The new Clinical Conductor contains a myriad of enhancements that foster more precise reporting and analysis.
Advertisement
Bio-Optronics announces its Clinical Conductor CTMS has been updated with enhancements that include:
- Adverse Event (AE/SAE) management enhancements (e.g. wizards for reporting, audit trails for review, document uploads, etc.)
- Billing compliance review functionality additions at the site level, as well as the enterprise level for sponsors, CROs, health systems and other networks
- Invoicing features that allow organizations to set invoicing caps, frequencies and much more.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
4
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
5





.png)



.png)



.png)
.png)
